William Haufe

1.7k total citations
14 papers, 1.0k citations indexed

About

William Haufe is a scholar working on Epidemiology, Hepatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, William Haufe has authored 14 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 9 papers in Hepatology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in William Haufe's work include Liver Disease Diagnosis and Treatment (14 papers), Liver Disease and Transplantation (6 papers) and Advanced MRI Techniques and Applications (6 papers). William Haufe is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Liver Disease and Transplantation (6 papers) and Advanced MRI Techniques and Applications (6 papers). William Haufe collaborates with scholars based in United States. William Haufe's co-authors include Claude B. Sirlin, Rohit Loomba, Jonathan Hooker, Carolyn Hernandez, Jeffrey Cui, Catherine A. Hooker, Archana Bhatt, Mark A. Valasek, Hamed Aryafar and Ricki Bettencourt and has published in prestigious journals such as Gastroenterology, Hepatology and Radiology.

In The Last Decade

William Haufe

14 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William Haufe United States 11 936 553 301 142 113 14 1.0k
Henry Lik-Yuen Chan Hong Kong 13 1.1k 1.2× 772 1.4× 269 0.9× 78 0.5× 173 1.5× 21 1.2k
Catherine A. Hooker United States 8 683 0.7× 349 0.6× 287 1.0× 108 0.8× 96 0.8× 10 759
Phirum Nguyen United States 12 1.6k 1.7× 909 1.6× 581 1.9× 68 0.5× 200 1.8× 14 1.7k
M. Andreoletti Italy 5 762 0.8× 419 0.8× 293 1.0× 18 0.1× 123 1.1× 8 844
S. Francioso Italy 12 486 0.5× 245 0.4× 245 0.8× 33 0.2× 104 0.9× 24 621
Claire Wartelle‐Bladou France 9 565 0.6× 326 0.6× 222 0.7× 23 0.2× 89 0.8× 20 643
Yoshitaka Takuma Japan 16 680 0.7× 699 1.3× 107 0.4× 56 0.4× 285 2.5× 31 1.0k
Alexandra Schlein United States 14 370 0.4× 225 0.4× 64 0.2× 122 0.9× 75 0.7× 22 465
Stella Maris Martínez Argentina 9 539 0.6× 419 0.8× 56 0.2× 48 0.3× 77 0.7× 20 639
Vincent Thibault France 4 757 0.8× 334 0.6× 338 1.1× 12 0.1× 163 1.4× 9 849

Countries citing papers authored by William Haufe

Since Specialization
Citations

This map shows the geographic impact of William Haufe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Haufe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Haufe more than expected).

Fields of papers citing papers by William Haufe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Haufe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Haufe. The network helps show where William Haufe may publish in the future.

Co-authorship network of co-authors of William Haufe

This figure shows the co-authorship network connecting the top 25 collaborators of William Haufe. A scholar is included among the top collaborators of William Haufe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Haufe. William Haufe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Park, Charlie C., Catherine A. Hooker, Jonathan Hooker, et al.. (2018). Assessment of a high‐SNR chemical‐shift‐encoded MRI with complex reconstruction for proton density fat fraction (PDFF) estimation overall and in the low‐fat range. Journal of Magnetic Resonance Imaging. 49(1). 229–238. 10 indexed citations
2.
Haufe, William, Tanya Wolfson, Catherine A. Hooker, et al.. (2017). Accuracy of PDFF estimation by magnitude‐based and complex‐based MRI in children with MR spectroscopy as a reference. Journal of Magnetic Resonance Imaging. 46(6). 1641–1647. 20 indexed citations
3.
Middleton, Michael S., William Haufe, Jonathan Hooker, et al.. (2017). Quantifying Abdominal Adipose Tissue and Thigh Muscle Volume and Hepatic Proton Density Fat Fraction: Repeatability and Accuracy of an MR Imaging–based, Semiautomated Analysis Method. Radiology. 283(2). 438–449. 39 indexed citations
4.
Patel, Janki, Ricki Bettencourt, Jeffrey Cui, et al.. (2016). Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis. Therapeutic Advances in Gastroenterology. 9(5). 692–701. 130 indexed citations
5.
Hamilton, Gavin, Kang Wang, Jonathan Hooker, et al.. (2016). Agreement between region-of-interest- and parametric map-based hepatic proton density fat fraction estimation in adults with chronic liver disease. Abdominal Radiology. 42(3). 833–841. 5 indexed citations
6.
Loomba, Rohit, Jeffrey Cui, Tanya Wolfson, et al.. (2016). Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study. The American Journal of Gastroenterology. 111(7). 986–994. 155 indexed citations
7.
Cui, Jeffrey, Phirum Nguyen, Heather Hofflich, et al.. (2016). Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial. Journal of Hepatology. 65(2). 369–376. 265 indexed citations
8.
Cui, Jeffrey, Phirum Nguyen, Heather Hofflich, et al.. (2016). 949 Sitagliptin Versus Placebo in the Treatment of Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial. Gastroenterology. 150(4). S1055–S1055. 1 indexed citations
9.
Bettencourt, Ricki, Parambir S. Dulai, William Haufe, et al.. (2016). Magnetic resonance elastography identifies fibrosis in adults with alpha‐1 antitrypsin deficiency liver disease: a prospective study. Alimentary Pharmacology & Therapeutics. 44(3). 287–299. 24 indexed citations
10.
Hofflich, Heather, C. Hernandez, Richele Bettencourt, et al.. (2016). Sitagliptin Versus Placebo in the Treatment of Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial. Journal of Hepatology. 64(2). S192–S193. 8 indexed citations
11.
Cui, Jennifer Y., William Haufe, Carolyn Hernandez, et al.. (2015). Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non‐invasive diagnosis of advanced fibrosis in biopsy‐proven non‐alcoholic fatty liver disease: a prospective study. Alimentary Pharmacology & Therapeutics. 41(12). 1271–1280. 120 indexed citations
12.
Artz, Nathan S., William Haufe, Catherine A. Hooker, et al.. (2015). Reproducibility of MR‐based liver fat quantification across field strength: Same‐day comparison between 1.5T and 3T in obese subjects. Journal of Magnetic Resonance Imaging. 42(3). 811–817. 71 indexed citations
14.
Hamilton, Gavin, Michael S. Middleton, Jonathan Hooker, et al.. (2015). In vivo breath‐hold 1H MRS simultaneous estimation of liver proton density fat fraction, and T1 and T2 of water and fat, with a multi‐TR, multi‐TE sequence. Journal of Magnetic Resonance Imaging. 42(6). 1538–1543. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026